Completed

Phase 4 of Efficacy and Patient Satisfaction of Miralax and Gatorade Versus Movi Prep

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

comparing 2 drugs on their effect on the bowel preparation for colonoscopy

+ comparing 2 drugs on their effect on the bowel preparation for colonoscopy

Drug
Who is being recruted

Treatment Adherence and Compliance+12

+ Behavior

+ Colonic Diseases

From 18 to 80 Years
+4 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Screening Study

Phase 4
Interventional
Study Start: February 2012
See protocol details

Summary

Principal SponsorRush University Medical Center
Last updated: August 2, 2023
Sourced from a government-validated database.Claim as a partner

Study start date: February 1, 2012

Actual date on which the first participant was enrolled.

Study is the purpose of evaluating patient satisfaction and at the same time efficacy of the bowel regimen in cleansing the colon

NCT01695863
Principal SponsorRush University Medical Center
Last updated: August 2, 2023
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

150 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Screening Study

Screening studies test new methods to find diseases or risk factors early—before any symptoms appear. This helps catch health issues sooner, when they may be easier to treat.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 80 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Treatment Adherence and ComplianceBehaviorColonic DiseasesDigestive System DiseasesDigestive System NeoplasmsGastrointestinal DiseasesGastrointestinal NeoplasmsIntestinal DiseasesIntestinal NeoplasmsNeoplasmsNeoplasms by SiteRectal DiseasesHealth BehaviorColorectal NeoplasmsPatient Satisfaction

Criteria

1 inclusion criteria required to participate
outpatient colonoscopy for screening for other Gi related problems
3 exclusion criteria prevent from participating
Chronic Kidney Disease (CKD)
Severe Congestive Heart Failure (CHF)
less than age 18 or more than 80 years

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
miralax with dulcolax and gatorade efficacy evaluated by colonoscopy and patient satisfaction evaluated by patient questionnaire

Group II

Experimental
Efficacy of split dose moviprep on cleansing colon for colonoscopy and patient satisfaction with the regimen

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Rush Unversity Medical Center

Chicago, United StatesOpen Rush Unversity Medical Center in Google Maps
CompletedOne Study Center